IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES TAKEDA SUBSIDIARY LISTING
Takeda Subsidiary Listing
The fol low ing is a list of the main phar ma ceu ti cal sub sid iar ies and rep re sen ta tive of fices of the Takeda
group. The in for ma tion is taken from the IMSWorld pub li ca tion IMS Com pany Search. Sub sid iary de -
tails are ob tained us ing a va ri ety of in for ma tion sources, in clud ing send ing ques tion naires di rectly to the
com pany in each coun try, as well as in for ma tion pro vided by the com pa nies which are pro filed. The prod -
uct, ther a peu tic range and sales in for ma tion is taken from the IMS MI DAS database.
� AUSTRIA
TAKEDA PHARMA
Full Name: Takeda Pharma Ges.m.b.H.
Street Ad dress: Seidengasse 33-35, A-1070
Wien
Tel: +43 1 524 40 64
Fax: +43 1 524 40 66
Home Page: www.takeda.at
De scrip tion: Sales/detailer. Prod uct ranges in -
clude: phar ma ceu ti cal prod ucts (pre scrip tion).
Es tab lished 1993. 72 phar ma ceu ti cal em ploy ees
in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 21-50 (2007)
Con tacts (Pharm): Chair man: Dr Helmut
Hasibeder
Sub sid iary of: Takeda Pharma, Ger many
(100%)
Phar ma ceu ti cal Sales: US$ 60-65 mil lion
Prod ucts (% of Sales by Lead ing 5):
95-100%
Ther a peu tic Classes (% of Sales by Lead ing
5): 95-100%
Dose Forms (% of Sales by Lead ing 5): n.a.
Prin ci pal Prod ucts:
BLOPRESS PLUS (an gio ten sin-II an tag o nist com -
bi na tion)
TRENANTONE (cytostatic hor mone)
BLOPRESS (an gio ten sin-II an tag o nist plain)
ACTOS (antidiabetic oral)
AGOPTON (antiulcerant)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 47%
cytostatic hor mone ther apy 23%
drugs used in di a be tes 16%
ant ac ids/antiflatulents/antiulcerants 13%
hor mones pi tu itary and hy po tha lamic 1%
Lead ing Dose Forms:
tab lets 61%
vi als 24%
cap sules 13%
coated tab lets 2%
� CHINA
TIANJIN TAKEDA
Full Name: Tianjin Takeda Pharmaceuticals Co.,
Ltd
Street Ad dress: No. 11, Xinghua Road, Tianjin
Xiqing, Eco nomic De vel op ment Area, Tianjin
Tel: +86 22 23970011
Fax: +86 22 23972230
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, packager/as sem bler, im porter, ex porter, pro -
moter, sales/detailer. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion).
Established 1994.
Con tacts (Pharm): Chair man: Shun Baowei;
Com mer cial Op er a tions: Philip Huang; Man u fac -
ture: Yukio Araki; Mar ket Re search: Shan Yong;
Re search & De vel op ment: Lilly Liang; Gen eral
Con tact: Hideyuki Matsumoto
Sub sid iary of: Takeda, Ja pan (75%)
� FRANCE
TAKEDA
Full Name: Laboratoires Takeda
Street Ad dress: 15 Quai de Dion Bou ton, 92 816
Puteaux Cedex
Tel: +33 1 46 25 16 16
Fax: +33 1 46 97 00 11
Email: con tact_com mu ni ca tion@labo-takeda.fr
Home Page: www.takeda.fr
De scrip tion: De vel oper, im porter, ex porter, pro -
moter, sales/detailer, packager/as sem bler, dis -
trib u tor. Prod uct ranges in clude: phar ma ceu ti cal
prod ucts (branded, pre scrip tion, non-pre scrip -
tion), hos pi tal pharmaceuticals. Es tab lished 1978.
480 phar ma ceu ti cal employees in 2006.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 320 (2006)
Con tacts (Pharm): Chair man: Yves Lepine;
Com mer cial Op er a tions: Alexandre Beithelot;
© 2009 IMS Health In cor po rated or its af fil i ates Page 123